Related Experiment Video
Updated: Mar 11, 2026
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Cameron Griffiths1, Steven J Drews2,3, David J Marchant4
1Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Insights
Respiratory syncytial virus (RSV) causes severe illness and death in infants globally. Despite extensive research, effective vaccines and treatments for this common respiratory infection remain elusive.
Area of Science:
- Virology
- Pediatric Infectious Diseases
- Public Health
Background:
- Respiratory syncytial virus (RSV) is a major cause of infant hospitalization in North America and a leading cause of infant mortality worldwide.
- Limited therapeutic options exist for RSV infection, despite significant global health impact.
- RSV infection can exacerbate chronic airway diseases and lead to long-term respiratory issues, with emerging links to childhood asthma.
Purpose of the Study:
- To review current understanding of RSV replication, pathogenesis, diagnostics, and therapeutics.
- To explore the reasons behind the lack of an effective RSV vaccine despite numerous clinical trials.
- To reconcile the extensive knowledge on RSV with the scarcity of available treatments.
Main Methods:
- Literature review of RSV replication mechanisms.
- Analysis of pathogenesis and community transmission data.
- Evaluation of diagnostic and therapeutic developments.
Main Results:
- Significant advancements in understanding RSV biology and disease mechanisms.
- Persistent challenges in developing a safe and effective RSV vaccine.
- Continued limited availability of specific antiviral therapies for RSV.
Conclusions:
- Despite a large body of research, effective RSV prevention and treatment remain critical unmet needs.
- Further research is needed to bridge the gap between understanding RSV and clinical application.
- Addressing the global burden of RSV requires novel strategies for vaccine and therapeutic development.
Abstract:
Respiratory syncytial virus (RSV) infection is a significant cause of hospitalization of children in North America and one of the leading causes of death of infants less than 1 year of age worldwide, second only to malaria. Despite its global impact on human health, there are relatively few therapeutic options available to prevent or treat RSV infection. Paradoxically, there is a very large volume of information that is constantly being refined on RSV replication, the mechanisms of RSV-induced pathology, and community transmission. Compounding the burden of acute RSV infections is the exacerbation of preexisting chronic airway diseases and the chronic sequelae of RSV infection. A mechanistic link is even starting to emerge between asthma and those who suffer severe RSV infection early in childhood. In this article, we discuss developments in the understanding of RSV replication, pathogenesis, diagnostics, and therapeutics. We attempt to reconcile the large body of information on RSV and why after many clinical trials there is still no efficacious RSV vaccine and few therapeutics.
More Related Videos
Related Concept Videos
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: